We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OCP: Expect Final Rules on GMPs, Adverse Events by Year’s End
OCP: Expect Final Rules on GMPs, Adverse Events by Year’s End
April 5, 2012
The FDA is on track to issue final rules this year on adverse event reporting and cGMPs for device-drug combinations, according to Kristina Lauritsen, a scientific reviewer in the agency’s Office of Combination Products (OCP).